BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Stem cell
,
Avian flu virus
,
Doxycycline
,
rs3825942
,
PPARA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PR B
Summary
General Info
Curated Studies
Most Correlated Studies
Breast cancer gene expression profiles associated with ER, Her2, PR, clinical stage, and grade
Retinoic acid -induced gene expression in U937 monocytes and blasts from APL patients
Diffuse large B-cell lymphoma OCI-LY-10 cells treated with CC-122
Mammary epithelial cells overexpressing hPR-B treated with PR agonist R5020
Diffuse large B-cell lymphoma U-2932 cells depleted of PRDM11
Explore Curated Studies Results
Literature
Most Relevant Literature
PGRS Domain of Rv0297 of Mycobacterium tuberculosis Functions in A Calcium Dependent Manner.
PE_PGRS: Vital proteins in promoting mycobacterial survival and modulating host immunity and metabol…
Evolution of Antibodies to Epitopes of PE_PGRS51 in the Spectrum of Active Pulmonary Tuberculosis.
PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host …
PGRS domain structures: Doomed to sail the mycomembrane.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, …
Pilot Clinical Trial of PRS TB Regimen I - Phase II
A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ